Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. Fluidigm enables comprehensive cellular profiling of the immune system and the tumor microenvironment with proven mass cytometry and microfluidics technologies.
Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you gain new insights to reach your next research breakthrough.
Visit Fluidigm at AACR 2018 at Booth 3420 to learn how you can deeply profile tumors and the tumor immune response from every angle.
Featured products:
Meet the Experts Schedule |
|||||
Day |
Time |
Expert |
Institution |
Application |
System |
Sunday, April 15th |
2:00 – 3:00 pm |
David Rimm, PhD |
Yale School of Medicine |
Imaging Mass Cytometry |
Hyperion™ Imaging System |
Monday, April 16th |
2:00 – 3:00 pm |
Carsten Krieg, PhD |
Medical University of South Carolina |
Mass cytometry |
Helios™, a CyTOF® system |